- Home
- VTYX vs ELMD Comparison
VTYX vs ELMD Comparison
Compare VTYX & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- ELMD
- Stock Information
- Founded
- VTYX 2018
- ELMD 1992
- Country
- VTYX United States
- ELMD United States
- Employees
- VTYX N/A
- ELMD N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VTYX Health Care
- ELMD Health Care
- Exchange
- VTYX Nasdaq
- ELMD Nasdaq
- Market Cap
- VTYX 154.9M
- ELMD 172.2M
- IPO Year
- VTYX 2021
- ELMD 2010
- Fundamental
- Price
- VTYX $2.79
- ELMD $19.32
- Analyst Decision
- VTYX Buy
- ELMD Strong Buy
- Analyst Count
- VTYX 4
- ELMD 1
- Target Price
- VTYX $11.33
- ELMD $38.00
- AVG Volume (30 Days)
- VTYX 2.0M
- ELMD 121.5K
- Earning Date
- VTYX 08-07-2025
- ELMD 08-26-2025
- Dividend Yield
- VTYX N/A
- ELMD N/A
- EPS Growth
- VTYX N/A
- ELMD 60.99
- EPS
- VTYX N/A
- ELMD 0.79
- Revenue
- VTYX N/A
- ELMD $61,439,000.00
- Revenue This Year
- VTYX N/A
- ELMD $17.91
- Revenue Next Year
- VTYX N/A
- ELMD $11.70
- P/E Ratio
- VTYX N/A
- ELMD $24.18
- Revenue Growth
- VTYX N/A
- ELMD 14.85
- 52 Week Low
- VTYX $0.78
- ELMD $13.74
- 52 Week High
- VTYX $3.39
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- VTYX 62.76
- ELMD 37.60
- Support Level
- VTYX $1.95
- ELMD $19.81
- Resistance Level
- VTYX $2.51
- ELMD $21.20
- Average True Range (ATR)
- VTYX 0.17
- ELMD 0.89
- MACD
- VTYX -0.02
- ELMD -0.16
- Stochastic Oscillator
- VTYX 104.37
- ELMD 2.52
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.